Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression
    Published on 2024-03-11
    2 years ago
  • Late-adolescent onset of prefrontal endocannabinoid control of hippocampal and amygdalar inputs and its impact on trace-fear conditioning behavior
    Published on 2024-03-10
    2 years ago
  • Effect of serum concentrations of IL-6 and TNF-α on brain structure in anorexia nervosa: a combined cross-sectional and longitudinal study
    Published on 2024-03-08
    2 years ago
  • Reactivation of encoding ensembles in the prelimbic cortex supports temporal associations
    Published on 2024-03-06
    2 years ago
  • Developmental and molecular contributions to contextual fear memory emergence in mice
    Published on 2024-03-04
    2 years ago
  • Mediodorsal thalamus projection to medial prefrontal cortical mediates social defeat stress-induced depression-like behaviors
    Published on 2024-03-03
    2 years ago
  • Reply to Bisol: Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression
    Published on 2024-03-03
    2 years ago
« Previous 1 … 64 65 66 67 68 … 143 Next »
Journal of Psychopharmacology
  • Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
    Published on 2022-05-24
    4 years ago
  • Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain
    Published on 2022-05-21
    4 years ago
  • Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study
    Published on 2022-05-13
    4 years ago
  • Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report
    Published on 2022-05-12
    4 years ago
  • Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials
    Published on 2022-05-12
    4 years ago
  • The antidepressant effect and safety of non-intranasal esketamine: A systematic review
    Published on 2022-05-12
    4 years ago
  • Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole
    Published on 2022-05-05
    4 years ago
« Previous 1 … 64 65 66 67 68 … 134 Next »
European Neuropsychopharmacology
  • Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]
    Published on 2022-10-02
    3 years ago
  • A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
    Published on 2022-10-01
    3 years ago
  • Pros and cons of esketamine treatment in psychiatry
    Published on 2022-09-30
    3 years ago
  • The role of metformin as a treatment for neuropsychiatric illness
    Published on 2022-09-30
    3 years ago
  • Minor physical anomalies in bipolar disorder in comparison to healthy controls and schizophrenia: A systematic review and meta-analysis
    Published on 2022-09-21
    3 years ago
  • Elucidating neurobiological mechanisms of mania: Critical next steps
    Published on 2022-09-20
    3 years ago
  • Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study
    Published on 2022-09-06
    3 years ago
« Previous 1 … 64 65 66 67 68 … 154 Next »

   Pharma Pub